ClinicalTrials.Veeva

Menu

Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Haemostasis Embolisation

Treatments

Other: Biological data
Other: Clinical data
Other: Imaging data

Study type

Observational

Funder types

Other

Identifiers

NCT06301919
IRBN042024/CHUSTE

Details and patient eligibility

About

NBCA is a synthetic biodegradable cyanoacrylate basis glue, modified by the addition of a monomer with adhesive, hemostatic, and antiseptic properties.

Its use requires a steep learning curve to control emulsification of the NBCA/lipiodol mixture, and injection, to avoid non-target embolization.

The aim of this retrospective monocentric study was to evaluate safety and efficacy of use of NBCA as embolic agent in emergency setting.

Enrollment

122 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients referred to our hospital and treated by TAE with NBCA, based on clinical decisions in emergency and CT scan.

Exclusion criteria

  • Patients lost for follow-up, patients without preoperative CT.

Trial design

122 participants in 1 patient group

Included patients
Description:
All patients referred to our hospital and treated by TAE with NBCA, based on clinical decisions in emergency and CT scan.
Treatment:
Other: Imaging data
Other: Clinical data
Other: Biological data

Trial contacts and locations

1

Loading...

Central trial contact

Rémi GRANGE, MD; Sylvain GRANGE, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems